The Scientist

» miRNA, disease/medicine and evolution

Most Recent

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Defeating cancer is many times more difficult than planting a flag on our lunar satellite.

4 Comments

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

image: CDC Offers Advice to Limit Opioid Scripts

CDC Offers Advice to Limit Opioid Scripts

By | March 17, 2016

Aimed at primary care providers, the recommendations encourage non-narcotic alternatives or short-term opioid prescriptions and patient monitoring.

0 Comments

image: Brains Before Brawn

Brains Before Brawn

By | March 16, 2016

A newly described horse-size relative of Tyrannosaurus rex may help settle the question of how massive carnivorous dinosaurs took shape throughout the eons.

0 Comments

image: Less Chewing, More Doing

Less Chewing, More Doing

By | March 11, 2016

Food processing in early hominid populations might have played a key role in human evolution by increasing net energy uptake, researchers show.

3 Comments

image: Antibiotic Assistants

Antibiotic Assistants

By | March 9, 2016

Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech